Common use of Outstanding Agreements Clause in Contracts

Outstanding Agreements. Except in each case as set forth in a memorandum prepared by CN Pharma and previously furnished to Isodiol, as of the Effective Date neither CN Pharma nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Five Thousand Canadian Dollars (CAD5,000.00), (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by CN Pharma or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, presently owned or held, in whole or in part, by CN Pharma or its subsidiaries, (x) insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of CN Pharma and persons, firms, or corporations other than CN Pharma relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know- how, including without limitation thereto, to the best knowledge of CN Pharma, agreements entered into by such employees prior to the time they became employees of CN Pharma, or (xii) material contract or commitment not made in the ordinary course of business.

Outstanding Agreements. Except in each case as set forth in a memorandum prepared by CN Pharma Target and previously furnished to Isodiol, as of the Effective Date neither CN Pharma Target nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Five One Hundred Thousand Canadian Dollars (CAD5,000.00US$100,000), (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by CN Pharma Target or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-know- how, presently owned or held, in whole or in part, by CN Pharma Target or its subsidiaries, (x) insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of CN Pharma Target and persons, firms, or corporations other than CN Pharma Target relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know- know-how, including without limitation thereto, to the best knowledge of CN PharmaTarget, agreements entered into by such employees prior to the time they became employees of CN PharmaTarget, or (xii) material contract or commitment not made in the ordinary course of business.

Outstanding Agreements. Except in each case as set forth in a memorandum prepared by CN Pharma Xxxxxxx’x Brand and previously furnished to Isodiol, as of the Effective Date neither CN Pharma Xxxxxxx’x Brand nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Five Thousand Canadian Dollars (CAD5,000.00)$5,000, (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by CN Pharma Xxxxxxx’x Brand or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, presently owned or held, in whole or in part, by CN Pharma Xxxxxxx’x Brand or its subsidiaries, (x) DocuSign Envelope ID: 0779D3ED-9E31-473A-AE0D-07833195C273 insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of CN Pharma Xxxxxxx’x Brand and persons, firms, or corporations other than CN Pharma Xxxxxxx’x Brand relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know- know-how, including without limitation thereto, to the best knowledge of CN PharmaXxxxxxx’x Brand, agreements entered into by such employees prior to the time they became employees of CN PharmaXxxxxxx’x Brand, or (xii) material contract or commitment not made in the ordinary course of business.

Outstanding Agreements. Except in each case as set forth in a memorandum Schedule B prepared by CN Pharma Vital and previously furnished to IsodiolUPD, if any, as of the Effective Date Date, neither CN Pharma Vital nor any of its subsidiaries is a holder of or a party to any written or oral (i) contract for employment of any officer or other person other than its officers and Directorsdirectors, (ii) contract with any labor union, (iii) bonus, pension, profit sharing, retirement, stock purchase, stock option, insurance, or similar plan or practice in effect with respect to its employees or other persons, (iv) indenture of mortgage, debenture, indenture, loan or borrowing agreement, (v) bonding arrangement, including performance bond, (vi) continuing contract for future purchase, sales, lease or distribution of materials, services, supplies, products, or equipment involving annual payments in excess of Five Thousand Canadian U.S. Dollars (CAD5,000.00US $5,000), (vii) lease or other commitment for the rental of office space, storage or other facilities, (viii) contract or lease agreement for the acquisition or lease of motor vehicles, (ix) patent, patent application, patent right, patentable inventions, trademark, trademark registration and applications therefor, trade name, copyright, copyright registration and application therefor, patent license granted to or by CN Pharma Vital or its subsidiaries and in force or contracts with employees or others relating in whole or in part to disclosure, assignment or patenting of any inventions, discoveries, improvements, shop rights, processes, formulae or other know-how, presently owned or held, in whole or in part, by CN Pharma Vital or its subsidiaries, (x) insurance policy covering its properties, buildings machinery, equipment, and persons, firms or operations, or the life of any person, (xi) agreement between a present employee of CN Pharma Vital and persons, firms, or corporations other than CN Pharma Vital relating in whole or in art to disclosure, assignment or patenting of inventions, discoveries, improvements, shop rights, processes, formulae or other know- know-how, including without limitation thereto, to the best knowledge of CN PharmaVital, agreements entered into by such employees prior to the time they became employees of CN PharmaVital , or (xii) material contract or commitment not made in the ordinary course of business.